e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
QuantiFERON test interpretation in patients receiving immunosuppressive agents: an alert
Julie Belliere, Antoine Blancher
Source:
Eur Respir J , 49 (4) 1602102; DOI: 10.1183/13993003.02102-2016
Journal Issue:
April
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Julie Belliere, Antoine Blancher. QuantiFERON test interpretation in patients receiving immunosuppressive agents: an alert. Eur Respir J , 49 (4) 1602102; DOI: 10.1183/13993003.02102-2016
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Monitoring the efficacy of anti-TB therapy by using the QuantiFERON-TB Gold In tube test
Source: Eur Respir Rev 2008; 17: 74-75
Year: 2008
Monitoring the efficacy of anti-TB therapy by using the QuantiFERON-TB Gold in tube test
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007
Individualized treatment regimens with second line anti-TB drugs (SLD) compared to first line anti-TB drug (FLD) only in new pulmonary TB patients, culture confirmed with full sensibility at drug sensibility test (DST)
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011
Prednisolone treatment does affect the performance of the QuantiFERON in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis
Source: Annual Congress 2011 - Tuberculosis in special populations
Year: 2011
Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007
The assessment of the efficacy of a standard chemotherapy regimen in the treatment of new sputum-positive tuberculosis (TB) patients
Source: Eur Respir J 2001; 18: Suppl. 33, 340s
Year: 2001
Effects of corticosteroid treatment on the performance of QuantiFERON Gold In-Tube test in the diagnosis of latent tuberculosis infection
Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Year: 2010
Pre-chemotherapy drug sensitivity test for antitubercular drugs in India – is it essential?
Source: Eur Respir J 2005; 26: Suppl. 49, 649s
Year: 2005
Impact of drug resistance over sputum conversion in tubercular patients receiving re-treatment regimen
Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2011
Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients
Source: Eur Respir J 2007; 30: 945-950
Year: 2007
Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice
Source: Eur Respir J 2009; 33: 812-815
Year: 2009
Treatment out-come in acquired drug resistance tuberculous patients receiving tailored regimen based on sensitivity report
Source: Annual Congress 2008 - Outcomes of tuberculosis treatment
Year: 2008
Design of tuberculosis treatment regimens for drug-resistant and intolerant patients – patient and clinician perspectives
Source: International Congress 2018 – CC4 Tuberculosis
Year: 2018
Outcomes for multidrug-resistant tuberculosis patients with and without resistance to fluoroquinolones and second-line injectable drugs: A meta-analysis of individual patient data
Source: Annual Congress 2012 - Pros and cons of MDR- and XDR-TB treatment
Year: 2012
Comparative analysis of the efficacy of glucocorticosteroids and antimetabolite drugs in treatment of patients with pulmonary sarcoidosis
Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Year: 2019
Clinical efficacy of new anti-TB drug ²tubelon² during complex chemotherapy in patients with first-time diagnosed destuctive pulmonary TB
Source: Eur Respir J 2006; 28: Suppl. 50, 8s
Year: 2006
Outcome of drug resistant TB in hospital settings-a comparision of individualized treatment based on past history of anti-TB drugs with culture sensitivity guided treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 589s
Year: 2006
Tuberculosis after a borderline QuantiFERON result during screening before infliximab
Source: Eur Respir J, 52 (2) 1800913; 10.1183/13993003.00913-2018
Year: 2018
The diagnosis value of QuantiFERON-TB gold test at patients with active tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Evaluation of tuberculin responsiveness and booster effect in HIV negative chronic hemodialysis patients and compare of their results with standard skin anergy test
Source: Eur Respir J 2005; 26: Suppl. 49, 417s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept